Clinical trial
Polypill Strategy for Evidence-Based Management of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in an Underserved Patient Population
NCT05514938 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Polypill Strategy for Evidence-Based Management of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in an Underserved Patient Population
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2022
- Completion date
- June 5, 2025
- Enrollment
- 140 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, coronary artery disease, lipid disorder